Terug
Dagbereik
€ 22,11
€ 23,50
52-Weeksbereik
€ 5,89
€ 55,65
Volume
29.513
50D / 200D Gem.
€ 25,90
/
€ 31,71
Vorige Slotkoers
€ 22,87
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 429,0 | 0,4 |
| P/B | 59,2 | 2,9 |
| ROE % | 14,8 | 3,9 |
| Net Margin % | 29,0 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
Geen toekomstige schattingen beschikbaar
No quarterly estimates available
Dividend History
Yield
0,00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
ROE of 14,83% — decent returns on equity
Net margin of 28,99% shows strong profitability
Debt/Equity of 0,00 — conservative balance sheet
Generating 2,08M in free cash flow
P/E of 428,95 — premium valuation
PEG of 0,40 suggests growth is underpriced
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)21,95%
Earnings (1Y)5,29%
FCF Growth (3Y)-31,62%
Kwaliteit
Return on Equity
14,83%
ROIC8,71%
Net Margin28,99%
Op. Margin24,38%
Veiligheid
Debt / Equity
0,00
Current Ratio10,71
Interest Coverage0,00
Waardering
P/E Ratio
428,95
Forward P/EN/A
P/B Ratio59,21
EV/EBITDA504,21
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 21,95% | Revenue Growth (3Y) | -41,04% |
| Earnings Growth (1Y) | 5,29% | Earnings Growth (3Y) | -51,32% |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 8,19M | Net Income (TTM) | 2,37M |
| ROE | 14,83% | ROA | 12,54% |
| Gross Margin | 71,90% | Operating Margin | 24,38% |
| Net Margin | 28,99% | Free Cash Flow (TTM) | 2,08M |
| ROIC | 8,71% | FCF Growth (3Y) | -31,62% |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 10,71 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 428,95 | Forward P/E | N/A |
| P/B Ratio | 59,21 | P/S Ratio | 124,35 |
| PEG Ratio | 0,40 | Forward PEG | N/A |
| EV/EBITDA | 504,21 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 0,20% | ||
| Market Cap | 1,02B | Enterprise Value | 1,01B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | 8,19M | 6,71M | 23,54M | 4,43M |
| Net Income | 2,37M | 2,25M | 10,01M | 2,54M |
| EPS (Diluted) | 0,06 | 0,01 | 0,07 | 0,03 |
| Gross Profit | 5,89M | 3,36M | 12,56M | 2,54M |
| Operating Income | 2,00M | 1,96M | 10,20M | 2,46M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Total Assets | 18,92M | 15,81M | 13,96M | 4,92M |
| Total Liabilities | 1,73M | 993.060,0 | 1,41M | 2,38M |
| Shareholders' Equity | 17,19M | 14,82M | 12,55M | 2,54M |
| Total Debt | 0,0 | 0,0 | 0,0 | 0,0 |
| Cash & Equivalents | 11,76M | 9,69M | 7,10M | 4,18M |
| Current Assets | 18,53M | 15,75M | 13,94M | 4,92M |
| Current Liabilities | 1,73M | 993.060,0 | 1,41M | 2,38M |